AMD TAB 50 MG
MAGNESIUM HVP CHELATE : 50 MG MANGANESE HVP CHELATE : 1.6 MG SELENIUM HVP CHELATE : .025 MG ZINC HVP CHELATE : 3.4 MG ASCORBIC ACID : 250 MG IRON HVP CHELATE : 5.6 MG CHROMIUM HVP CHELATE : .025 MG IODINE : .025 MG DL-METHIONINE : 50 MG · DIN 00705780 · SEROYAL INTERNATIONAL INC.
Health Canada status: CANCELLED POST MARKET
What is AMD TAB?
AMD TAB 50 MG contains MAGNESIUM HVP CHELATE : 50 MG MANGANESE HVP CHELATE : 1.6 MG SELENIUM HVP CHELATE : .025 MG ZINC HVP CHELATE : 3.4 MG ASCORBIC ACID : 250 MG IRON HVP CHELATE : 5.6 MG CHROMIUM HVP CHELATE : .025 MG IODINE : .025 MG DL-METHIONINE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00705780, held by SEROYAL INTERNATIONAL INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00705780 |
|---|---|
| Brand name | AMD TAB |
| Generic / active ingredient | MAGNESIUM HVP CHELATE : 50 MG MANGANESE HVP CHELATE : 1.6 MG SELENIUM HVP CHELATE : .025 MG ZINC HVP CHELATE : 3.4 MG ASCORBIC ACID : 250 MG IRON HVP CHELATE : 5.6 MG CHROMIUM HVP CHELATE : .025 MG IODINE : .025 MG DL-METHIONINE : 50 MG |
| Manufacturer | SEROYAL INTERNATIONAL INC. |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | V06DX OTHER COMBINATIONS OF NUTRIENTS |
| AHFS class | 88:30.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Sep-1996 |
| Original market date | 1988-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code V06DX OTHER COMBINATIONS OF NUTRIENTS. 0 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BORACELLE CAPSULES 500MG | 16.8 % | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 00702633 |
| BORACELLE OIL OF BORAGE SEED 23.5% GAMMA LIN | 87.216 MG | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 02122723 |
| BORAGE OIL | 187.5 MG | CAPSULE | TECNODIS DISTRIBUTIONS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02241145 |
| BORAGE OIL 500MG - CAP | 115 MG | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 02182335 |
| EFAMOL PURE LIQUID EVENING PRIMROSE OIL | 84 MG | LIQUID | EFAMOL RESEARCH INC. | CANCELLED POST MARKET | DIN 02231013 |
| EVENING PRIMROSE OIL | 370 MG | CAPSULE | TECNODIS DISTRIBUTIONS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02241144 |
| EVENING PRIMROSE OIL CAPSULES | 240 MG | CAPSULE | WAH SHUN COMPANY | CANCELLED (UNRETURNED ANNUAL) | DIN 02237447 |
| PMG PROTOMORPHOGEN BEEF PROSTATE 164MGMS | 164 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00190934 |
| PRIMROSA EVENING PRIMROSE OIL CONCENTRATE (1200MG) | 240 MG | CAPSULE | PURITY PLUS ADVANCED NATURALS | CANCELLED POST MARKET | DIN 02229568 |
| Q-10 PLUS | 30 MG | CAPSULE | THORNE RESEARCH INC. | CANCELLED POST MARKET | DIN 02231938 |
Who else supplies OTHER COMBINATIONS OF NUTRIENTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER COMBINATIONS OF NUTRIENTS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.